Halo Biomedical Investment I Limited - Net Worth and Insider Trading
Halo Biomedical Investment I Limited Net Worth
The estimated net worth of Halo Biomedical Investment I Limited is at least $261 Million dollars as of 2024-06-22. Halo Biomedical Investment I Limited is the 2201 Interest of corporation controlled by you of ImmuneOnco Biopharmaceuticals (Shanghai) Inc and owns about 18,000,000 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) stock worth over $261 Million. Details can be seen in Halo Biomedical Investment I Limited's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Halo Biomedical Investment I Limited has not made any transactions after 2023-09-05 and currently still holds the listed stock(s).
Transaction Summary of Halo Biomedical Investment I Limited
Halo Biomedical Investment I Limited Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Halo Biomedical Investment I Limited owns 1 companies in total, including ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) .
Insider Ownership Summary of Halo Biomedical Investment I Limited
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HKSE:01541 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc | 2023-09-05 | 2201 Interest of corporation controlled by you |
Halo Biomedical Investment I Limited Latest Holdings Summary
Halo Biomedical Investment I Limited currently owns a total of 1 stock. Halo Biomedical Investment I Limited owns 18,000,000 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) as of September 5, 2023, with a value of $261 Million.
Latest Holdings of Halo Biomedical Investment I Limited
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HKSE:01541 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc | 2023-09-05 | 18,000,000 | 14.48 | 260,640,000 |
Holding Weightings of Halo Biomedical Investment I Limited
Halo Biomedical Investment I Limited Form 4 Trading Tracker
According to the SEC Form 4 filings, Halo Biomedical Investment I Limited has made a total of 1 transactions in ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in ImmuneOnco Biopharmaceuticals (Shanghai) Inc is the sale of 18,000,000 shares on September 5, 2023, which brought Halo Biomedical Investment I Limited around $0.
Insider Trading History of Halo Biomedical Investment I Limited
- 1
Halo Biomedical Investment I Limited Trading Performance
Halo Biomedical Investment I Limited Ownership Network
Ownership Network List of Halo Biomedical Investment I Limited
Ownership Network Relation of Halo Biomedical Investment I Limited
![Insider Network Chart](https://static.gurufocus.com/insider-network.png)
Halo Biomedical Investment I Limited Owned Company Details
What does ImmuneOnco Biopharmaceuticals (Shanghai) Inc do?
Who are the key executives at ImmuneOnco Biopharmaceuticals (Shanghai) Inc?
Halo Biomedical Investment I Limited is the 2201 Interest of corporation controlled by you of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. Other key executives at ImmuneOnco Biopharmaceuticals (Shanghai) Inc include Ho Yao , CHENG YIQUAN , and 2102 Investment manager LAV Asset Management (Hong Kong) Limited .
ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) Insider Trades Summary
Over the past 18 months, Halo Biomedical Investment I Limited made 1 insider transaction in ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) with a net sale of 0. Other recent insider transactions involving ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) include a net sale of 0 shares made by LAV Biosciences Fund V, L.P. , a net sale of 0 shares made by LAV GP V, L.P. , and a net sale of 0 shares made by Halo Biomedical LP .
In summary, during the past 3 months, insiders sold 0 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541)'s detailed insider trading history can be found in Insider Trading Tracker table.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Insider Transactions
Halo Biomedical Investment I Limited Mailing Address
Above is the net worth, insider trading, and ownership report for Halo Biomedical Investment I Limited. Currently GuruFocus does not have mailing address information for Halo Biomedical Investment I Limited.